Hokkaido-Losartan/hydrochlorothiazide Investigation For End Point (H-LIFE study): Multi-center observational study on blood pressure control and cardio- and renoprotective effects of an ARB/ diuretic combination in hypertensive patients in Hokkaido, Japan.

Trial Profile

Hokkaido-Losartan/hydrochlorothiazide Investigation For End Point (H-LIFE study): Multi-center observational study on blood pressure control and cardio- and renoprotective effects of an ARB/ diuretic combination in hypertensive patients in Hokkaido, Japan.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms H-LIFE
  • Most Recent Events

    • 22 Jan 2014 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan record.
    • 22 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 22 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top